230 related articles for article (PubMed ID: 23600831)
1. Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome.
Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Verhulst SJ; Ransohoff RM
Clin Exp Immunol; 2013 Jun; 172(3):427-36. PubMed ID: 23600831
[TBL] [Abstract][Full Text] [Related]
2. BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy.
Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Colliver JA; Ness JM; Ransohoff RM
J Neuroinflammation; 2013 Jan; 10():10. PubMed ID: 23324534
[TBL] [Abstract][Full Text] [Related]
3. CCR7 signaling in pediatric opsoclonus-myoclonus: upregulated serum CCL21 expression is steroid-responsive.
Pranzatelli MR; Tate ED; McGee NR; Ransohoff RM
Cytokine; 2013 Oct; 64(1):331-6. PubMed ID: 23764550
[TBL] [Abstract][Full Text] [Related]
4. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome.
Pranzatelli MR; Tate ED; Hoefgen ER; Swan JA; Colliver JA
Cytokine; 2008 Oct; 44(1):26-32. PubMed ID: 18675552
[TBL] [Abstract][Full Text] [Related]
6. Optic neuritis: chemokine receptor CXCR3 and its ligands.
Sørensen TL; Roed H; Sellebjerg F
Br J Ophthalmol; 2004 Sep; 88(9):1146-8. PubMed ID: 15317705
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of CXCL10, CXCL11, CXCL12 and CXCL13 chemokines in serum and cerebrospinal fluid in patients with tick borne encephalitis (TBE).
Zajkowska J; Moniuszko-Malinowska A; Pancewicz SA; Muszyńska-Mazur A; Kondrusik M; Grygorczuk S; Swierzbińska-Pijanowska R; Dunaj J; Czupryna P
Adv Med Sci; 2011; 56(2):311-7. PubMed ID: 22008312
[TBL] [Abstract][Full Text] [Related]
8. Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS.
Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Ransohoff RM; Ness JM; Colliver JA
J Neuroimmunol; 2012 Feb; 243(1-2):81-8. PubMed ID: 22264765
[TBL] [Abstract][Full Text] [Related]
9. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
Karin N
Front Immunol; 2020; 11():976. PubMed ID: 32547545
[TBL] [Abstract][Full Text] [Related]
10. Chemokine/cytokine profiling after rituximab: reciprocal expression of BCA-1/CXCL13 and BAFF in childhood OMS.
Pranzatelli MR; Tate ED; Travelstead AL; Verhulst SJ
Cytokine; 2011 Mar; 53(3):384-9. PubMed ID: 21211990
[TBL] [Abstract][Full Text] [Related]
11. Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome.
Yoon KC; Park CS; You IC; Choi HJ; Lee KH; Im SK; Park HY; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):643-50. PubMed ID: 19850844
[TBL] [Abstract][Full Text] [Related]
12. Concentration gradient of CXCL10 and CXCL11 between the cerebrospinal fluid and plasma in children with enteroviral aseptic meningitis.
Cavčić A; Tešović G; Gorenec L; Grgić I; Benić B; Lepej SŽ
Eur J Paediatr Neurol; 2011 Nov; 15(6):502-7. PubMed ID: 21703889
[TBL] [Abstract][Full Text] [Related]
13. Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: A retrospective pilot study.
Pranzatelli MR; Allison TJ; Tate ED
Eur J Paediatr Neurol; 2018 Jul; 22(4):586-594. PubMed ID: 29555260
[TBL] [Abstract][Full Text] [Related]
14. Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS.
Pranzatelli MR; McGee NR; Tate ED
J Neuroimmunol; 2018 Aug; 321():150-156. PubMed ID: 29685330
[TBL] [Abstract][Full Text] [Related]
15. Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome.
Fühlhuber V; Bick S; Kirsten A; Hahn A; Gerriets T; Tschernatsch M; Kaps M; Preissner KT; Blaes F; Altenkämper S
J Neuroimmunol; 2009 May; 210(1-2):87-91. PubMed ID: 19339060
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
17. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4
Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of chemokines in psoriasis.
Lima XT; Oliveira RT; Braga FG; Magalhães RF; Mamoni RL; Blotta MH
Autoimmunity; 2015 Feb; 48(1):57-60. PubMed ID: 25117898
[TBL] [Abstract][Full Text] [Related]
19. Cytokines, cytokine antagonists, and soluble adhesion molecules in pediatric OMS and other neuroinflammatory disorders.
Pranzatelli MR; Tate ED; McGee NR; Colliver JA
J Neurol Sci; 2013 Mar; 326(1-2):53-8. PubMed ID: 23380454
[TBL] [Abstract][Full Text] [Related]
20. Circulating interferon-γ-inducible Cys-X-Cys chemokine receptor 3 ligands are elevated in humans with aortic aneurysms and Cys-X-Cys chemokine receptor 3 is necessary for aneurysm formation in mice.
Gallo A; Saad A; Ali R; Dardik A; Tellides G; Geirsson A
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):704-10. PubMed ID: 21962843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]